USD 0.73
(0.0%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 | 37.04 Million AUD | 34.36% |
2023 | 27.23 Million AUD | 57.84% |
2022 | 17.25 Million AUD | 7.94% |
2021 | 15.98 Million AUD | 13.83% |
2020 | 14.04 Million AUD | 559.68% |
2019 | 2.12 Million AUD | 56.21% |
2018 | 1.36 Million AUD | 9.65% |
2017 | 1.24 Million AUD | 36.12% |
2016 | 913.14 Thousand AUD | 24.66% |
2015 | 732.48 Thousand AUD | -1.77% |
2014 | 745.7 Thousand AUD | -6.88% |
2013 | 800.8 Thousand AUD | -13.0% |
2012 | 920.48 Thousand AUD | -18.61% |
2011 | 1.13 Million AUD | -11.61% |
2010 | 1.27 Million AUD | -12.65% |
2009 | 1.46 Million AUD | 108.77% |
2008 | 701.69 Thousand AUD | -42.92% |
2007 | 1.22 Million AUD | -43.71% |
2006 | 2.18 Million AUD | 55.49% |
2005 | 1.4 Million AUD | -28.58% |
2004 | 1.96 Million AUD | 62.1% |
2003 | 1.21 Million AUD | 160.46% |
2002 | 465.76 Thousand AUD | -42.82% |
2001 | 814.6 Thousand AUD | 61.66% |
2000 | 503.88 Thousand AUD | 19.22% |
1999 | 422.63 Thousand AUD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 28.15 Million AUD | 63.16% |
2024 Q4 | 37.04 Million AUD | 0.0% |
2024 Q2 | 28.15 Million AUD | 0.0% |
2024 Q3 | 36.59 Million AUD | 29.98% |
2024 FY | 37.04 Million AUD | 36.0% |
2023 Q3 | 27.23 Million AUD | 3.41% |
2023 Q1 | 26.33 Million AUD | 52.63% |
2023 Q4 | 17.25 Million AUD | -36.64% |
2023 FY | 27.23 Million AUD | 57.84% |
2023 Q2 | 26.33 Million AUD | 0.0% |
2022 Q4 | 17.25 Million AUD | 0.0% |
2022 Q3 | 17.25 Million AUD | 4.43% |
2022 FY | 17.25 Million AUD | 7.94% |
2022 Q1 | 16.52 Million AUD | 3.36% |
2022 Q2 | 16.52 Million AUD | 0.0% |
2021 Q4 | 15.98 Million AUD | 0.0% |
2021 FY | 15.98 Million AUD | 13.83% |
2021 Q2 | 14.28 Million AUD | 0.0% |
2021 Q1 | 14.28 Million AUD | 1.72% |
2021 Q3 | 15.98 Million AUD | 11.9% |
2020 Q4 | 14.04 Million AUD | 0.0% |
2020 Q1 | 5.06 Million AUD | 138.13% |
2020 FY | 14.04 Million AUD | 559.68% |
2020 Q3 | 14.04 Million AUD | 177.02% |
2020 Q2 | 5.06 Million AUD | 0.0% |
2019 FY | 2.12 Million AUD | 56.21% |
2019 Q1 | 1.57 Million AUD | 15.31% |
2019 Q4 | 2.12 Million AUD | 3.15% |
2019 Q2 | 1.57 Million AUD | 0.0% |
2019 Q3 | 2.06 Million AUD | 31.33% |
2018 Q1 | 1.28 Million AUD | 3.02% |
2018 FY | 1.36 Million AUD | 9.65% |
2018 Q2 | 1.28 Million AUD | 0.0% |
2018 Q3 | 1.21 Million AUD | -4.85% |
2018 Q4 | 1.36 Million AUD | 11.86% |
2017 Q2 | 593.22 Thousand AUD | 0.0% |
2017 Q1 | 593.22 Thousand AUD | -35.03% |
2017 FY | 1.24 Million AUD | 36.12% |
2017 Q4 | 1.24 Million AUD | 16.21% |
2017 Q3 | 1.06 Million AUD | 80.3% |
2016 Q3 | 705.83 Thousand AUD | -76.8% |
2016 FY | 913.14 Thousand AUD | 24.66% |
2016 Q2 | 3.04 Million AUD | 0.0% |
2016 Q4 | 913.14 Thousand AUD | 29.37% |
2016 Q1 | 3.04 Million AUD | 315.43% |
2015 Q3 | 489.07 Thousand AUD | 40.14% |
2015 FY | 732.48 Thousand AUD | -1.77% |
2015 Q4 | 732.48 Thousand AUD | 49.77% |
2015 Q2 | 348.99 Thousand AUD | 0.0% |
2015 Q1 | 348.99 Thousand AUD | -53.2% |
2014 Q4 | 745.7 Thousand AUD | 50.74% |
2014 FY | 745.7 Thousand AUD | -6.88% |
2014 Q1 | 394.9 Thousand AUD | -50.69% |
2014 Q2 | 394.9 Thousand AUD | 0.0% |
2014 Q3 | 494.7 Thousand AUD | 25.27% |
2013 Q1 | 379.99 Thousand AUD | -58.72% |
2013 FY | 800.8 Thousand AUD | -13.0% |
2013 Q4 | 800.8 Thousand AUD | 49.78% |
2013 Q3 | 534.66 Thousand AUD | 40.7% |
2013 Q2 | 379.99 Thousand AUD | 0.0% |
2012 FY | 920.48 Thousand AUD | -18.61% |
2012 Q4 | 920.48 Thousand AUD | 0.0% |
2011 Q4 | 1.13 Million AUD | 0.0% |
2011 FY | 1.13 Million AUD | -11.61% |
2010 Q4 | 1.27 Million AUD | 0.0% |
2010 FY | 1.27 Million AUD | -12.65% |
2009 FY | 1.46 Million AUD | 108.77% |
2009 Q4 | 1.46 Million AUD | 0.0% |
2008 Q4 | 701.69 Thousand AUD | 0.0% |
2008 FY | 701.69 Thousand AUD | -42.92% |
2007 FY | 1.22 Million AUD | -43.71% |
2007 Q4 | 1.22 Million AUD | 0.0% |
2006 Q4 | 2.18 Million AUD | 0.0% |
2006 FY | 2.18 Million AUD | 55.49% |
2005 FY | 1.4 Million AUD | -28.58% |
2005 Q4 | 1.4 Million AUD | 0.0% |
2004 Q4 | 1.96 Million AUD | 0.0% |
2004 FY | 1.96 Million AUD | 62.1% |
2003 Q4 | 1.21 Million AUD | 0.0% |
2003 FY | 1.21 Million AUD | 160.46% |
2002 Q4 | 465.76 Thousand AUD | 0.0% |
2002 FY | 465.76 Thousand AUD | -42.82% |
2001 Q4 | 814.6 Thousand AUD | 0.0% |
2001 FY | 814.6 Thousand AUD | 61.66% |
2000 FY | 503.88 Thousand AUD | 19.22% |
2000 Q4 | 503.88 Thousand AUD | 0.0% |
1999 FY | 422.63 Thousand AUD | 0.0% |
1999 Q4 | 422.63 Thousand AUD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
IR-Med Inc. | 634 Thousand USD | -5742.744% |
BioElectronics Corporation | 16.62 Million USD | -122.844% |
Medical Supply International USA, Inc. | 677.61 Thousand USD | -5366.665% |
CVR Medical Corp. | - USD | -Infinity% |
Össur hf. | 688.8 Million USD | 94.622% |
Polarean Imaging plc | 2.58 Million USD | -1335.475% |
Avitar, Inc. | 11.59 Million USD | -219.514% |
AVITA Medical, Inc. | 19.86 Million USD | -86.47% |
Manhattan Scientifics, Inc. | 2.11 Million USD | -1648.961% |
Zecotek Photonics Inc. | 5.86 Million USD | -531.206% |
QHSLab, Inc. | 2.05 Million USD | -1700.784% |
Wellstar International, Inc. | 55.99 Million USD | 33.841% |
Össur hf. | 688.8 Million USD | 94.622% |
Bionovate Technologies Corp | - USD | -Infinity% |
EKF Diagnostics Holdings plc | 16.08 Million USD | -130.359% |
Escalon Medical Corp. | 2.94 Million USD | -1156.401% |
Aurora Spine Corporation | 6.65 Million USD | -456.742% |
BrainsWay Ltd. | 15.31 Million USD | -141.89% |
Lattice Biologics Ltd. | - USD | -Infinity% |
NewCardio, Inc. | 6.01 Million USD | -516.085% |
Hamilton Thorne Ltd. | 45.84 Million USD | 19.196% |
Vivos Inc. | 245 Thousand USD | -15019.345% |
MicroPort Scientific Corporation | 2.48 Billion USD | 98.51% |
Kelyniam Global, Inc. | 1.01 Million USD | -3556.997% |
REMSleep Holdings, Inc. | 275.61 Thousand USD | -13340.174% |
CYduct Diagnostics, Inc. | 2.44 Million USD | -1412.078% |
Nanomix Corporation | 14.81 Million USD | -150.041% |
Theraclion SA | 13.01 Million EUR | -184.583% |
Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
Wellness Center USA, Inc. | 5.12 Million USD | -622.904% |
Positron Corporation | 2.02 Million USD | -1728.383% |
Rafina Innovations Inc. | - USD | -Infinity% |
Electromedical Technologies, Inc. | 3.62 Million USD | -922.957% |
Lombard Medical, Inc. | 53.79 Million USD | 31.139% |
ALR Technologies Inc. | 24.5 Million USD | -51.163% |
Stratec SE | 271.97 Million USD | 86.38% |
Vycor Medical, Inc. | 4.31 Million USD | -757.919% |
Heart Tronics, Inc. | 1.09 Million USD | -3283.574% |
Nu-Med Plus, Inc. | 2.35 Million USD | -1470.426% |
Perimeter Medical Imaging AI, Inc. | 5.47 Million USD | -576.391% |
SANUWAVE Health, Inc. | 65.59 Million USD | 43.527% |
VMS Rehab Systems, Inc. | 201.36 USD | -18396304.45% |
Guided Therapeutics, Inc. | 5.47 Million USD | -576.584% |
Ingen Technologies, Inc. | 5.7 Million USD | -548.791% |
Odyssey Group International, Inc. | 6.61 Million USD | -460.263% |
United American Healthcare Corporation | 119 Thousand USD | -31028.571% |
ECGI Holdings, Inc. | 11.94 Million USD | -210.234% |
Capital Group Holdings, Inc. | 1.32 Million USD | -2697.843% |
ADM Tronics Unlimited, Inc. | 1.44 Million USD | -2461.16% |
Urologix, Inc. | 12.64 Million USD | -192.969% |
Rapid Therapeutic Science Laboratories, Inc. | 5.39 Million USD | -586.482% |
Nexeon MedSystems Inc. | 8.48 Million USD | -336.701% |
SS Innovations International, Inc. | 11.18 Million USD | -231.3% |
Qualis Innovations, Inc. | 525.38 Thousand USD | -6950.612% |
Smith & Nephew plc | 4.76 Billion USD | 99.222% |
NIOX Group Plc | 9.8 Million USD | -277.909% |
Fuse Medical, Inc. | 15.11 Million USD | -145.154% |
Broncus Holding Corporation | 10.43 Million USD | -255.084% |
Brain Scientific Inc. | 7.42 Million USD | -398.801% |
Pressure BioSciences, Inc. | 33.8 Million USD | -9.583% |
Health Logic Interactive Inc. | 794.08 Thousand USD | -4564.889% |